帕金森病的特点是维生素B6依赖的炎症性 kynurenine 途径功能障碍
Edward Wilson1, Jacob Umans1, Michelle Swarovski1
1Stanford University.
Research square
|October 14, 2024
概括
帕金森病与血液和CSF中改变的金氨酸途径代谢物有关,反映了炎症和维生素B6缺乏. 这些代谢变化准确地识别了帕金森病,并与临床症状相关联.
科学领域:
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,具有运动和非运动症状.
- 病理包括神经元损失,多巴胺缺乏和α-synuclein聚合物.
- 患PD越来越多地与代谢失调有关,特别是金氨酸通路 (KP).
研究的目的:
- 为了研究 kynurenine 途径 (KP) 在帕金森病中的作用.
- 在PD患者和健康对照者之间比较血液和脑脊液 (CSF) 中的KP代谢物.
- 探索KP代谢物,炎症,维生素B6状态和PD临床特征之间的关系.
主要方法:
- 一项多中心研究涉及177名PD参与者和158名未受损害的对照.
- 使用液体染色学-并联质谱法在血和CSF中量化金氨酸途径代谢物.
- 代谢物水平,炎症标志物,维生素B6状态和临床PD严重程度之间的相关性分析.
主要成果:
- 在PD患者的血和CSF中增加了神经刺激性林酸/氨酸 (QA/KA) 的比率.
- 增加的QA水平与CSF tau以及运动和非运动PD症状相关.
- KP代谢物准确地分类了PD参与者 (AUC = 0.897) 并确定了不同的临床子组.
结论:
- kynurenine 途径是 PD 中大脑外围交叉通话的关键位置.
- 通过KP的代谢失调整整合了炎症和B族维生素状态,影响PD.
- KP代谢物概况提供了潜在的诊断生物标志物和对PD异质性的见解.
更多相关视频
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
3.3K
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.5K
相关概念视频
01:15Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
01:24Parkinson's Disease: Treatment
231
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
231
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:20Inborn Errors of Metabolism
140
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
140